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Background: SAIATU is a program of specially trained in-home social assistance and companionship which, since
February 2011, has provided support to end-of-life patients, enabling the delivery of better clinical care by healthcare
professionals in Osakidetza (Basque Health Service), in Guipúzcoa (Autonomous Community of the Basque Country).
In January 2012, a retrospective observational study was carried out, with the aim of describing the characteristics of
the service and determining if the new social service and the associated socio-health co-ordination had produced
any effect on the use of healthcare resources by end-of-life patients.
The results of a comparison of a cohort of cases and controls demonstrated evidence that the program could reduce
the use of hospital resources and promote the continuation of living at home, increasing the home-based activity of
primary care professionals.
The objective of this study is to analyse whether a program of social intervention in palliative care (SAIATU) results in
a reduction in the consumption of healthcare resources and cost by end-of-life patients and promotes a shift
towards a more community-based model of care.
Method/design: Comparative prospective cohort study, with randomised selection of patients, which will
systematically measure patient characteristics and their consumption of resources in the last 30 days of life, with and
without the intervention of a social support team trained to provide in-home end-of-life care.
For a sample of approximately 150 patients, data regarding the consumption of public healthcare resources, SAIATU
activity, home hospitalisation teams, and palliative care will be recorded. Such data will also include information
dealing with the socio-demographic and clinical characteristics of the patients and attending carers, as well as
particular characteristics of patient outcomes (Karnofsky Index), and of the outcomes of palliative care received
(Palliative Outcome Scale).
Ethical approval for the study was given by the Clinical Research Ethics Committee of Euskadi (CREC-C) on 10 Dec 2012.
Discussion: The results of this prospective study will assist in verifying or disproving the hypothesis that the in-home
social care offered by SAIATU improves the efficiency of healthcare resource usage by these patients (quality of life,
symptom control).
This project represents a dramatic advance with respect to other studies conducted to date, and demonstrates how,
through the provision of personnel trained to provide social care for patients in the advanced stages of illness, and
through strengthening the co-ordination of such social services with existing healthcare system resources, the resulting
holistic structure obtains cost savings within the health system and improves the efficiency of the system as a whole.
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In the developed world, some 10,000 people per million
population die every year. Some 70% of the total popula-
tion lives through a period of terminal illness lasting sev-
eral months before their eventual death, whether it be a
type of cancer (2,500 cases per million population) or
the final stage of deterioration of non-oncological ill-
nesses (approximately 4,500 cases per million popula-
tion) [1]. It has been accepted internationally that the
largest proportion of healthcare costs incurred by a citi-
zen are generated in the final months of life. We are
therefore discussing the largest source of costs to the
healthcare system, an issue to which insufficient atten-
tion has been paid. In these cases, both the symptoms
themselves and the complexity of accompanying circum-
stances cause a high degree of suffering in the patient
and a social and family crisis in his immediate environ-
ment, as well as incurring the largest share of healthcare
expenditure in the life of each respective patient.
Palliative Care (PC) [2] has been scientifically demon-
strated as a truly effective tool in both welfare and organ-
isational terms, complementing appropriate medication
and medical care with psychological, social and spiritual
support for patients and their careers.
In addition, the final period of illness is accompanied in
nearly all cases by a more or less prolonged period of func-
tional deterioration, leading inexorably to the development
of a state of dependence on the part of the terminally ill
patient, often accompanied by tremendous socio-familial
complexity. Thus, the enormous diversity of psycho-social
factors that surround every case can generate a wide range
of needs, of greater or lesser severity, which need to be
attended to routinely, and which, conversely, do not fall
within the competencies provided by the health system it-
self. In fact, such needs are better understood within the
social sphere and often include, among others:
- Need for attention to patient dependency: assistance
with performing the basic and instrumental activities
of daily living; reducing as far as possible the loss of
sensory capabilities, and facilitating measures which
can compensate for such deterioration; training in
habits that improve personal autonomy; early warning
of loss of autonomy; measures for the safety and
protection of the patient; and adaptation of the
environment.
- Needs of carers and the patient’s social support
network: information about available support services;
training and capacity-building for professional and/or
family carers; development of communication skills to
facilitate dialogue with the patient; family rest and
respite; reconciliation of care with the professional life
of the carer; psychosocial support to prevent burnout;
and the exchange of experiences with other carers.- Protection of the patient’s social role: decision-making
autonomy and the communication of the final will;
companionship; spiritual expression; leisure and
entertainment; privacy or intimacy; interpersonal and
social relationships.
While the health system is aimed at ensuring compre-
hensive care for patients and families, addressing those
aspects related to healthcare, and encouraging valid
solutions to social problems, reality demonstrates that
this is often insufficient. When healthcare teams conduct
in-home visits, a solid care structure is required, capable
of performing all necessary tasks. Indeed, the problem is
two-fold: increasingly, such structures are dwindling as a
result of the crisis in informal caregivers, while the as-
sistance required, due to patient complexity, calls for an
increasing degree of skill.
In effect, changes to the socio-demographic structure,
the ageing population, and the increasing incidence of
chronic illness, have been accompanied by the weaken-
ing of traditional social support networks, diminishing
the available number of informal caregivers who, histor-
ically, would have offered in-home care as a matter of
course [3].
The development of in-home care from the social sec-
tor and its expected growth since the entry into force of
the Law for the Promotion of Autonomy and Care for
People in a Dependent Situation [4] are not yet sufficient
to meet current assistance needs. Furthermore, in the
absence of clearly defined alternatives, they will evidently
be inadequate to provide family support and patient
care for increasingly complex cases in the future, espe-
cially if improvements to training procedures are not
implemented.
Effectiveness and efficiency of palliative care at a
global level
The incorporation of Support Teams for palliative patients
into traditional models of patient care (primary attention,
specialist care, emergency, residential centres) offers ef-
fectiveness in outcomes such as improving control of
symptoms [5], reduction of health-care costs [6], appro-
priate process management, improvements in quality of
life outcomes, and patient and family satisfaction [7,8].
At the hospital level, Palliative Care (PC) support teams
act with the advice and support of clinical professionals to
resolve the specific and complex problems of terminal
patients and ensure co-ordination between levels of care.
The incorporation of these specialised teams has been
demonstrated to effectively reduce the length of hospital
stays [9].
This is one of the most commonly used indicators to
measure the cost effectiveness of Palliative Care teams.
The reduction of average stay length in a hospital patient
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and indirect costs of hospital care, which is often un-
necessarily prolonged [10]. One study conducted in the
United States demonstrated a reduction in costs of US
$1.8 million per year after the introduction of PC teams
in the hospital [9]. Another study, carried out in Spain,
found a reduction in the average length of hospital stay,
from 25.5 days to 19.9 days, which coincides with the
averages of other studies [11]. This study was conducted
over two different time periods, one in 1992 under a
traditional care regime and one in 2001 with the pres-
ence of functional PC teams. Costs were reduced from
5,068 € per patient per year in 1992 under the traditio-
nal hospital model to 1,963 € per patient per year in
2001 [12].
The results of other studies conclude that a reduction
of 40-70% in hospital costs could be achieved through
the provision of specialised Palliative Care support teams
[13]. In addition to providing adequate symptom con-
trol, the interventions of PC support teams reduced the
number of medical tests and interventions, as well as
offering support to families, occasionally allowing them
to leave the hospital with the security of relying on an
onsite support team [14].
Similar results have been encountered in hospital Pal-
liative Care Units (PCUs), where the costs associated
with patient care are lower than those in acute care hos-
pitals. In Smith’s 2006 study [15], a cost reduction of
57% was achieved under the Palliative Care mode. Simi-
larly, in a comparative study between PCUs and hospital
units, the average cost per patient in the PCU was cal-
culated at US$700 per day, compared with a cost of
US $2,500 per day in Intensive Care units [16]. Signifi-
cant reductions in hospital admissions have also been
found in comparative studies in other countries [17]. In
addition, as the PCUs are used in the most complex
cases, the consistency and effectiveness demonstrated in
the follow-up of patients in acute crisis has facilitated a
reduction in hospital admissions, visits to emergency
departments and intensive care units [17]. Early identifi-
cation of patients in terminal stages and their transfer to
specialised units allows for the appropriate planning of
care and ensures its continuity, leading to effective con-
trol of symptoms, reduction of nonspecific treatments,
and improvements in quality of life for both patients and
their families
In the home environment, the teams offer support and
advice to primary care professionals through consult-
ation, direct assistance with the evaluation of patients
and families, and the design of appropriate therapeutic
intervention strategies.
This support ensures co-ordination between levels of
care and improves the portfolio of primary care services
[18] with regard to their responsiveness to the complexitiesof terminal patients. For its part, home-based palliative
care has demonstrated effectiveness in:
- Reducing the number of hospital admissions, visits to
emergency departments and other specialties, and
hospital stays (reduction of 8 days on average) [19],
which translates to a decrease in healthcare costs
[20,21]. In addition, this type of care allows for a
reduction in unnecessary visits to primary care
providers and in the length of stays in residential
centres.
- The highest rate of deaths at home, which translates to
an improvement in the satisfaction and quality of life
of both patient and family. In addition to generating
emotional and psychological advantages and permitting
better control of symptoms, death at home translates
to a reduction in hospital costs, which can result in a
saving of some 4,000 € for hospital stays per patient
[22]. Today, the majority of deaths occur in hospital,
which could entail greater economic costs (around 58%
currently, and rising to 65% by the year 2030). This is
despite evidence showing that between 56% and 65% of
patients prefer to die at home [23].
Thus, it is evident that Palliative Care experiences are
proving successful in terms of quality, effectiveness, effi-
ciency and cost savings. Indeed, it would be reasonable
to anticipate that, based on current socio-demographic
trends regarding the prevalence of chronic illnesses and
the lack of family caregivers at home, social healthcare
development models should begin to promote appropri-
ate social welfare support of community networks in
order to make them genuinely useful to healthcare.
At first glance, this solution may appear unfeasible,
given that the increased cost of providing special train-
ing for home-based assistants would be nearly impos-
sible to contend with in the current environment of
socio-economic crisis and budgetary cuts. Nevertheless,
hypotheses that defend the efficiency of social healthcare
could make it clear that, through investment in better so-
cial care, the health system could encounter part of the
solution for better healthcare, and, through improved effi-
ciency, reduce overall healthcare costs over time.
Despite the fact that the majority of patients within
the Basque Country (60%) die in hospitals, hospitalisa-
tion does not always offer better quality of life. Further-
more, the practice of hospitalisation leads to the
saturation of emergency services and intensive care units
[19,24]. As has been demonstrated in other studies con-
sulted in the literature, the majority of people prefer not
to have to die in a hospital, which is cold, routine, im-
personal, and high-cost. Rather, people have a strong
preference for dying at home, which suggests that pa-
tient care should be focused there. This, in turn, would
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stage patients at home.
SAIATU program
The SAIATU in-home care program is a social innovation
project launched in February 2011 in Guipúzcoa, with the
aim of providing a set of in-home social support services
to complement clinical palliative care, in order to improve
comprehensive care for people with advanced and ter-
minal illness and their families. This has entailed widening
the scope of the classic model of primary care in palliative
patients, expanding the traditional model to a cross-
cutting action framework.
Currently, the program provides care in complex social
situations, or in cases requiring attendance by clinical
teams to provide appropriate symptom control, which
requires the assistance of a social support network to facili-
tate the interventions of Osakidetza palliative care teams.
This new care model for Palliative Care patients forms
part of an innovative approach, which aims to co-
ordinate social services and healthcare in the field of pal-
liative care. This approach is currently thriving in other
health systems internationally, including the Canadian
and British health systems, and seeks to provide both
the best possible comprehensive care and efficiency in
the provision of complementary health and social ser-
vices [25].
SAIATU has been the first such experience in Spain,
and the first internationally which combines the quanti-
fication, analysis and impact assessment of the reduction
of healthcare resource usage by end-of-life patients, based
on a pilot study of in-home social care for palliative care
patients in the Basque Country.
The evaluation of the program, conducted in January
2012, has attempted to compare the difference in the in-
tensity of health care provided to end-of-life patients in
traditional services and in specialised Palliative Care ser-
vices, but, for the first time, adding to the second group
the effect of a social service trained in Palliative Care.
On the one hand, the pilot experience has been of
enormous utility in properly channelling the program’s
contribution to the real needs of the patients and their
families, clarifying what should be the vision and mis-
sion of the program, and determining that SAIATU
should position itself as a Specialised Social Program, in
close co-ordination with the current health system (pri-
mary care, specialised care, and home hospitalisation).
On the other hand, the results of the pilot experience
have yielded data suggesting that the SAIATU program:
- Reduces the consumption of health care resources on
the part of program users.
- Facilitates staying at home for the patient, in
compliance with patients’ preference for dying at home.- Increases the number of home-based activities
developed by Primary Care.
- Has yielded satisfactory outcomes for the families of
patients questioned in the course of the study.
These results are highly striking and, if confirmed,
would be of tremendous importance for improving the
efficiency of the health system, and for the development
of models for complementary action between the social
and health sectors. However, with the current work, the
results should be treated as the results of a descriptive
and comparative study, retrospective in nature, and thus
the scientific strength of the results is highly relative.
For this reason, a prospective study with greater sam-
ple size, enabling the validation with sufficient strength
and validity of the results obtained in this work, is con-
sidered of great interest to society in general and the
Basque country in particular. Such a study would be one
of the first to provide clear evidence of the efficiency
gains offered by complementary and co-ordinated action
in the social and health sectors and, without doubt, the
first worldwide in the field of palliative care.
General objective
To analyse whether a program of social intervention in
palliative care (SAIATU) results in a decrease in the con-
sumption of healthcare resources and cost by end-of-life
patients, and produces a shift towards a more community-
based model of care.
Specific objectives
- Describe the average profile of healthcare resource
consumption of a retrospective cohort (patients who
died from malignant neoplasm) in the last 30 days of
life by diagnosis and age group.
- Quantify and compare the costs of the use of
healthcare resources in the cohorts of patients with
and without SAIATU intervention.
- Compare quality of life in the cohorts of patients with
and without SAIATU intervention.
Methods/design
Hypothesis
The intervention of SAIATU (a resource for the social
support of end-of-life patients) improves efficiency in
the use of healthcare resources in end-of-life patients,
decreasing the consumption of hospital resources and
increasing the home-based activities conducted by Pri-
mary Care in the last 30 days of life.
Location and date of study
The study will be conducted in the provinces of Guipúzcoa.
Period of study: September 2012 - October 2013.
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The study was designed in two phases.
Phase 1: RETROSPECTIVE study to register a control cohort
of patients who died from malignant neoplasm
The objective of this study is to determine the baseline
risk of the principal variable, consumption of resources in
the population of patients who die from malignant
neoplasm.
Thus, the study characterises, by primary diagnosis (cri-
teria and rules established by the International Statistical
Classification of Diseases 10 [ICD-10] [26]) and age, the
behaviour of different malignant neoplasms, with regard to
resource consumption: number of visits to or consulta-
tions with Primary Care, number of external consultations,
number of visits to hospital emergency departments, num-
ber of hospital admissions, average length of stay, and days
in home hospitalisation.
Time of study: time series of 4 years, to be determined
based on Osakidetza records and the mortality register.
Based on the results of this study and on the hypoth-
esis of the decrease in, and improved efficiency of, re-
source consumption through the intervention of support
programs, formulated as a result of the retrospective ob-
servational study carried out, the sample size of cohorts
and subgroups will be defined for Phase 2: PROSPECTIVE
cohort study.
For this analysis, the error will be established at α = 5%
with a statistical significance of 80% (error β = 20%). The
sample size of each subgroup n will be the maximum of
the sample sizes obtained for the comparison of means
or proportions of the main variables in each subgroup.
For the comparison of two means:




S2 = variance in the quantitative variable of the control
group
d =Minimum value of the difference to be detected
(quantitative values)
For the comparison of two proportions:




p =Mean of the two proportions pA y pB
The parameters will be analysed with the statistical
software SPSS 15.0 for Windows.A descriptive study will be conducted on the consump-
tion of healthcare resources by diagnosis and age group in
the last 30 days of life. The descriptive study will include
measures of central tendency (mean), confidence intervals
at 95% for the population mean, and contingency tables
(frequencies) for each recorded variable.
Phase 2. Study of PROSPECTIVE cohorts, assigned by
randomised blocks
The study will be initiated with two cohorts:
1. Exposed cohort: comprising patients who will be
attended by SAIATU, without prejudice to the care
received from the public health system.
2. Control cohort: comprising patients who will be cared
for exclusively through the public health system.
The evolution of the disease over the course of the
study will determine the different healthcare mechan-
isms (Primary Care, Specialised Care (SC), Home Hospi-
talisation (HH)) that will intervene in the care of each
patient, so that, at the end of the study, the two initial
cohorts will be divided into 4 subgroups:
1) Exposed cohort1.1. Patients attended by Primary Care + SC + SAIATU
2.2. Patients attended by Primary Care + SC + HH +
SAIATU
2) Control cohort
a. Patients attended by Primary Care + SC
b. Patients attended by Primary Care + SC + HH
(Figure 1)
Population for Study
This study will comprise oncology patients from the
health districts of Guipúzcoa, attended by the Basque
Health Service.
Assuming that 2,500 people per million population die
each year from malignant neoplasm, and taking into ac-
count that the population of Guipúzcoa is 709,607 inha-
bitants, it is estimated that the eligible population for
this study is 1,774 deaths from malignant neoplasm per
year. For a period of 10 months of prospective study,
this corresponds to a population of 1,478 deaths from
malignant neoplasm in these provinces.
Although the final number of patients for inclusion
will be calculated during the design of the prospective
study itself, after the results of Phase 1, it is estimated
that the resulting sample size could allow some 150 pa-
tients to be studied. This sample, which would correspond








- Patients attended by Primary Care + 
Specialised Care (SC)+ SAIATU 
- Patients attended by Primary Care + SC + 
Home Hospitalisation (HH) 
Randomised selection of patients
Criteria for inclusion:
- Documented presence of incurable, progressive and 
advanced oncological disease, capable of systematic 
treatment in the home.
- Little or no possibility of response to oncological 
treatment with a curative intent.
- Limited life prognosis.




-Patients attended by Primary Care + SC
-Patients attended by Primary Care + SC + HH
SECONDARY VARIABLES. 
Socio-demographic data.
Place of death: home or hospital.
Level of functional dependency: Karnofsky index <50.
Characterisation of the principal carer.
Quality of care in Palliative Care, measured according to the Palliative Outcome Scale and validated in Spanish
VARIABLES TO RECORD . OSAKIDETZA INFORMATION SYSEMS
The variables for analysis are the following:
- Number of nursing home visits.
- Number of visits to nursing home health clinics.
- Number of home visits by the family doctor.
- Number of visits to the family doctor’s clinic. 
- Number of specialist outpatient consultations.
- Number of visits to hospital emergency departments.
- Number of hospital admissions.
- Number of days admitted to hospital.
VARIABLES TO RECORD. HOME HOSPITALISATION
Number of visits by Home Hospitalisation.
- Number of calls to Home Hospitalisation.
- Grieving process (depending on the activity undertaken during the period).
- Number of bereavement support visits.
- Number of bereavement support calls.
VARIABLES TO RECORD . SAIATU
A model will be designed to record the daily activity of SAIATU professionals, which will allow researchers to keep track of activity during the progression of the disease and 
throughout the grieving process.
Variables to be recorded:
During the progression of the illness:
- Number of visits by SAIATU.
- Number of calls from SAIATU.
During the grieving process:
- Number of bereavement support visits by SAIATU.
- Number of bereavement support calls by SAIATU.
COST OF CARE.The cost of SAIATU’s activities will be estimated by reference to budgetary information. Cost estimates for Hospitals, Primary Care, Home Hospitalisation and 
Palliative Care will be arrived at by multiplying costs by the quantity of resources consumed by each patient.
Figure 1 Flow chart. Study of prospective cohorts, assigned by randomised blocks.
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spect to its representativeness of the total population in
both provinces.
Criteria for inclusion and exclusion from the study sample
population
Criteria for inclusion:
- Documented presence of incurable, progressive and
advanced oncological disease, capable of systematic
treatment in the home.
- Little or no possibility of response to oncological
treatment with a curative intent.
- Limited life prognosis.
- Presence of a principal carer.
Criteria for exclusion:
- Death or disability of the family carer.
- Withdrawal from the Basque public health system
- Absence of compliance with informed consent.
Variables and sources of information
Main variable: Consumption of resources
Primary and specialised care Records of patient activity
will be obtained from Osakidetza’s information systems.
The variables for analysis are the following:
- Number of nursing home visits.
- Number of visits to nursing home health clinics.
- Number of home visits by the family doctor.
- Number of visits to the family doctor’s clinic.
- Number of specialist outpatient consultations.
- Number of visits to hospital emergency departments.
- Number of hospital admissions.
- Number of days admitted to hospital.
Home hospitalisation A formula will be designed to
record the daily activity of Home Hospitalisation profes-
sionals during the period of care.
Variables to record:
- Number of visits by Home Hospitalisation.
- Number of calls to Home Hospitalisation.
- Grieving process (depending on the activity
undertaken during the period).
◦ Number of bereavement support visits.
◦ Number of bereavement support calls.
SAIATU
A model will be designed to record the daily activity of
SAIATU professionals, which will allow researchers tokeep track of activity during the progression of the dis-
ease and throughout the grieving process.
Variables to be recorded:
- During the progression of the illness:
◦ Number of visits by SAIATU.
◦ Number of calls from SAIATU.
- During the grieving process:
◦ Number of bereavement support visits by SAIATU.
◦ Number of bereavement support calls by SAIATU.
Costs of care
The cost of SAIATU’s activities will be estimated by
reference to budgetary information. Cost estimates for
Hospitals, Primary Care, Home Hospitalisation and Pal-
liative Care will be arrived at by multiplying costs by the
quantity of resources consumed by each patient.
Where budgetary information about the activities of
Hospitals, Primary Care and Home Hospitalisation is
available, a calculation will be made multiplying costs by
the quantity of resources consumed by each patient.
Secondary variables:
- Socio-demographic data.
- Place of death: home or hospital.
- Level of functional dependency: Karnofsky index <50.
- Characterisation of the principal carer.
- Quality of care in Palliative Care, measured according
to the Palliative Outcome Scale and validated in
Spanish [27].
Analysis of variables
The parameters will be analysed using the statistical soft-
ware SPSS 15.0 for Windows.
A descriptive study will be conducted on the consump-
tion of healthcare resources by subgroup in the last 30
days of life. The descriptive study will include measures
of central tendency, confidence intervals at 95% for the
population mean, and contingency tables (frequencies)
for each of the recorded variables.
Each subgroup will be analysed by age, sex, and main
diagnosis.
For the comparison of proportions, Pearson’s Χ2 test,
or, when appropriate, Fisher’s exact test will be used to
calculate relative risk (RR), absolute risk reduction (ARR)
and the number needed to treat (NNT) with 95% confi-
dence interval.
The Student T-test will be applied to calculate the
equality of means for independent samples in the case of
continuous variables, upon confirmation of the condi-
tions of normality and homoscedasticity.
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program will be calculated on the basis of the activities
performed by the program’s professionals, measured in
hours of care. Based on the actual time spent on patients,
the total cost will be distributed between each of the
activities.
Calculations of unit costs per activity, taking into ac-
count the number of times each activity is performed for
the period under analysis, will finally be performed.Ethical considerations
Ethical approval for the study was given by the Clinical
Research Ethics Committee of Euskadi (CRE-C) on 10
Dec 2012.Discussion
SAIATU could become a benchmark for an innovative
model of home-based palliative care, focusing on the
complementary aspects of healthcare; namely, social
welfare and companionship. It is the first program to de-
fine a specific portfolio of services directed at the social
welfare and support of end-of-life patients. This will
allow the creation of new professional profiles to carry
out this type of work, as well as clarifying which capabil-
ities should be fostered in the training of in-home sup-
port staff, so that in the future they will be able to
care for patients with advanced disease and high levels
of dependency (a basic tool to cope with the socio-
demographic changes we are currently undergoing).
The current project could be a graphic demonstration
of an important solution to improved efficiency in the
health system, through investment in resources outside
the health system; in this case, in the social sector.
Should the current hypothesis be confirmed, the cre-
ation of a reserve of appropriately trained home care
professionals would lead to a more community-based
model of healthcare, resulting in a more economical ex-
penditure of the total resources used in the integrated
care process.
If there is evidence of a difference between the cohorts
under study, it would be possible to estimate, based on
the incidence of the various diseases, the cost savings that
could be achieved through a program of professional train-
ing and communal resource procurement if the project
was extended the project to the entire Basque territory.
Taken as a whole, the results will allow for an analysis
of how the development of skilled social resources and
socio-health co-ordination, when applied to groups of
end-of-life patients, strengthens the overall efficiency of
both systems: healthcare and social welfare.
It is expected that the study will stratify oncological
patients by iso-resource consumption, according to the
average profile of end-of-life behaviour.It will be possible to assess the consumption of health-
care resources at different levels of care, with and without
the intervention of the SAIATU program, quantifying the
similarities and differences both in terms of activities
undertaken and in economic terms. Furthermore, it will
be possible to examine if there are statistically significant
differences in a study of sufficient methodological strength
and robustness.
Indirectly, the study will generate:
- Organisational and operational protocols for
programs such as SAIATU in the future.
- Work systems which utilise liaison committees for
assessment and co-ordination between different levels
of care and across sectors.
- Protocols for the primary assessment of the needs of
end-of-life patients, which take into account both
clinical and social aspects, supplementing the
assessment of the illness itself with an account of
patient’s degree of suffering, their level of dependence,
and their social support network, thus allowing for
better allocation of resources.
- Criteria for referrals between professionals of different
levels, according to the needs of patients and their
families.
Abbreviations
PC: Palliative care; PCU: Palliative care unit; HH: Home hospitalisation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The idea for this study was initially conceived by RN, EH, and GE. EH, JO and
SL designed the study’s methodology and contributed to the analysis of a
previous retrospective study on the SAIATU experience. NH coordinated the
interventions, as well as the inclusion of patients and variables in the study.
All authors have given final approval of the version submitted.
Acknowledgment
This project is financed through the Basque Foundation for Health
Innovation (ETORBIZI) from funds allocated for the development of socio-
health innovation in the Basque Country for the years 2012–2013.
A special mention of gratitude is made to the professionals of Osakidetza,
who have supported requests for information, professionals from Oberri and
Denokkin who contributed to the implementation of the SAIATU program,
and especially to all those professionals who work in the SAIATU program
and in Palliative Care services, providing care for all patients and families
who find themselves in an end-of-life situation in the Autonomous
Community of the Basque Country.
Translation: TRANScienci@
Author details
1Enterprising Solutions for Health, SL. Galia Puerto. Carretera de la Esclusa, 11,
CP.41014, Seville, Spain. 2O+berri, Basque Institute for Healthcare Innovation,
Basque Country, Spain. 3Association for the Promotion of Innovation
DENOKINN, Basque Country, Spain. 4SAIATU Program Coordinator,
Guipúzcoa, Spain.
Received: 12 November 2012 Accepted: 23 January 2013
Published: 30 January 2013
Molina et al. BMC Palliative Care 2013, 12:3 Page 9 of 9
http://www.biomedcentral.com/1472-684X/12/3References
1. Franks PJ, Salisbury C, Bonsaquet N, Wilkinson EK, Kite S, Naysmith A,
Higginson IJ: The level of need for palliative care: a systematic review of
the literature. Pall Med 2000, 14:93–104.
2. Estrategia en Cuidados Paliativos del Sistema Nacional de Salud. Madrid:







3. Estrategia para afrontar el reto de la cronicidad en Euskadi. Gobierno Vasco.







4. Ley 39/2006, de 14 de diciembre, de Promoción de la Autonomía
Personal y Atención a las personas en situación de dependencia. BOE
2006, 299:2006. Available in: http://www.boe.es/buscar/doc.php?id=BOE-A-
2006-21990.
5. Higginson I, Finlay I, Goodwin DM, Hood K, Edwards AG, Cook A, et al:
Is there evidence that palliative care teams alter end-of-life experiences
of patients and their caregivers? J Pain Symptom Manage 2003,
25(2):150–168.
6. Bruera E, Neumann C, Gagnon B, Brenneis C, Quan H, Hanson J: The impact
of a Regional Palliative Care Program on the cost of palliative care
delivery. J Pall Med 2000, 3(2):181–185.
7. Bausewein C, Daveson B, Benalia H, Simon ST, Higginson IJ: Outcome
Measurement in Palliative Care. In PRISMA, Reflecting the Positive Diversities of






8. Meier D: Increased access to palliative care and hospice services:
opportunities to improve value in health care. Milbank Q 2011, 89(3):343–380.
9. Cowan JD: Hospital charges for a community inpatient palliative care
program. Am J Hosp Palliat Care 2004, 21(3):177–190.
10. Luce JM, Rubenfeld GD: Can health care cost be reduced by limiting
intensive care at the end of life? Am J Respir Crtit Care Med 2002, 165:750–754.
11. García Pérez L, Linertová R, Martín Olivera R: Efectividad y coste efectividad de
las diferentes modalidades organizativas para la provisión de cuidados
paliativos. Madrid: Plan Nacional para el SNS del MSC. Servicio de Evaluación
del Servicio Canario de la Salud; Informes de Evaluación de Tecnologías
Sanitarias: SESCS Nº 2006/04; 2008.
12. Gomez-Batiste X, Tuca A, Corrales E, Porta-Sales J, Amor M, Espinosa J, et al:
Resource Consumption and Costs of Palliative Care Services in Spain: A
Multicenter Prospective Study. J Pain Symptom Manage 2006, 31(6):522–532.
13. Payne S, Coyne P, Smith T: The health economics of palliative care.
Oncology 2002, 16(6):801–808.
14. O’Mahohy S, Blank A, Zallman L, Selwyn PA: The benefits of a hospital-
based inpatient palliative care consultation service: Preliminary outcome
data. J Palliat Med 2005, 8(5).
15. Smith T, Coyne P, Cassel B: A high volume specialist palliative care unit
and team may reduce in hospital end of life care cost. J Palliat Med 2003,
6(5):699–705.
16. White K, Stover K, Cassek J, Smith T: Nonclinical outcomes of hospital
based palliative care. J Healthc Manag 2006, 51(4):260–273.
17. Meier DE: Palliative Care in hospitals. J of Hospital Medicine 2006, 1(1):21–28.
18. Real Decreto 1030/2006, de 15 de septiembre por el que se establece la cartera
de servicios comunes del Sistema Nacional de Salud y el procedimiento para





19. Lacampa P, Bermúdez C, Vallejo S, García L, Villegas R: Modelos organizativos
en cuidados paliativos. Comparación de consumo de recursos, Agencia de
Evaluación de Tecnologías Sanitarias de Andalucía. Madrid: Ministerio de
Sanidad y Consumo; 2009.
20. Serra-Prat M, Gallo P, Picaza JM: Home palliative care as a cost-saving
alternative: evidence from Catalonia. Palliat Med 2001, 15(4):271–278.
21. Gómez Batiste X, Tuca A, Corrales E: Resource consumption and cost of
palliative care services in Spain: a multicenter prospective study. J Pain
Symtom Manage 2006, 31:522–532.
22. Taylor D: Palliative care at home to get further funds if it saves money.
BMJ 2004, 328:544.3.
23. Gomes B, Higgison I: Where people die (1974—2030): past trends, future
projections and implications for care. Palliat Med 2008, 22(1):33–41.
24. Plan de Cuidados Paliativos: Atención a pacientes en la fase final de la vida







25. National End of Life Care Programe, Improving end of life care.: National
Health Service; 2010. Report of the Social Care Advisory Group of the





26. Organización Panamericana de la Salud: Clasificación Estadística Internacional
de Enfermedades y Problemas relacionados con la Salud, Décima revisión,
Volume 1–3. Washington DC: OPS; 1996.
27. Serra-Prat M, Nabal M, Santacruz V, Picaza Josep M, Trelis J: Traducción,
adaptación y validación de la Palliative Care Outcome Scale al español.
Med Clin 2004, 23(1):406–412.
doi:10.1186/1472-684X-12-3
Cite this article as: Molina et al.: Impact of a home-based social welfare
program on care for palliative patients in the Basque Country (SAIATU
Program). BMC Palliative Care 2013 12:3.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
